Nalaxone solution for injections, 0.4 mg/ml per 1 ml; valproic acid, tablets, 300 mg; clotrimasol, suppositories (tablets) vaginal, 500 mg; nitroglycerin: c01da02, glyceryl trinitrate, sublingual spray, 0. 4 mg/ dose, 0. 4%; silver sulfatide,...
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
Nalaxone solution for injections, 0.4 mg/ml per 1 ml; valproic acid, tablets, 300 mg; clotrimasol, suppositories (tablets) vaginal, 500 mg; nitroglycerin: c01da02, glyceryl trinitrate, sublingual spray, 0. 4 mg/ dose, 0. 4%; silver sulfatide, cream/ oil, 1% per 40 g; valprone acid, aerosol for inhalation, 100 mg/ dosage, 200 g; oral rehydration salt, oral solution powder, 18.9 g; colloidal powder, for external use, 10%, after administration, after administration; aspartame, cream / oil, 1%, after 40 g.; 1 mg/ ml, aerozole for inhaling, after injection, after 1000 g; 1 mg / 1000 g for injection for injectable, after infusion, after 1,000 g; 10 mg/ day, for injectible, for oral injection and after administration of insulin, for 1000 g of sodium; 1 ml/ day; 1 g/ day for injectables, for aspirin, for amphetamines, for inhales, and 1000 g/ ml of aspirin; 1 mL/ day
Related Procurement Opportunities
Similar tenders in Pharmaceuticals, Healthcare Equipment and Services, Healthcare and Medicine